abstract |
The present invention is caused, mediated and / or caused by the activation of piperidine and pyrazine derivatives and increased lysophosphatidic acid levels and / or autotaxin according to formulas (Ia), (Ib) and (II) as autotaxin inhibitors Or to the use of such compounds for the treatment and / or prevention of physiological and / or pathophysiological conditions, in particular different cancers, which are spread: |